Peer review reports
From: Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis
Original Submission |
19 Feb 2015 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Resubmission - Version 7 |
|
Submitted |
Manuscript version 7
|
Resubmission - Version 8 |
|
Submitted |
Manuscript version 8
|
Resubmission - Version 9 |
|
Submitted |
Manuscript version 9
|
Resubmission - Version 10 |
|
Submitted |
Manuscript version 10
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 11 |
|
Submitted |
Manuscript version 11
|
Publishing |
18 Sep 2015 |
Editorially accepted |
|
29 Sep 2015 |
Article published |
10.1186/s12872-015-0100-7
|
Learn about peer review